| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.0034 | 1 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.0058 | 1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |